Artemisia annua (Sweet Wormwood)

Artemisia annua — sweet wormwood, and known for centuries in China as qinghao — is one of the most important plants in the entire history of medicine. From it, scientists isolated artemisinin, the compound at the heart of the antimalarial drugs that today save hundreds of thousands of lives every year. That discovery earned a Nobel Prize, and it deserves to be celebrated. But this page has to make one distinction very clearly and very firmly, because lives depend on it: the purified, dose-controlled drug made from this plant is a frontline malaria treatment, while the raw herb, "Artemisia tea," or homemade tablets are not a safe or reliable substitute for treating malaria or any serious infection. Below we tell the true story of this remarkable plant, explain how its famous molecule works, and are honest about where the evidence is strong, where it is only preliminary, and where using the herb can do real harm.

What Artemisia annua Is (and What It Isn't)
The Artemisinin Story: A Genuine Triumph
The Drug Versus the Herb: The Distinction That Matters Most
How Artemisinin Works
Why Resistance Is the Central Concern
Other Research on the Herb and Artemisinin
Traditional, Culinary, and Antioxidant Aspects
Forms, Use, and the Standardization Problem
Safety and Cautions
The Honest Bottom Line
Research Papers
Connections
Featured Videos

What Artemisia annua Is (and What It Isn't)

Artemisia annua is an aromatic annual plant in the daisy family (Asteraceae), native to temperate Asia and now naturalized across much of the world. It grows quickly into a tall, feathery, fern-leaved bush with a distinctive sweet, resinous smell when crushed — which is why English speakers call it sweet wormwood or sweet Annie. In China it has been used for well over a thousand years under the name qinghao, most famously in remedies for intermittent fevers.

Because several plants share the genus name Artemisia and the common word "wormwood," it is easy to confuse them. They are genuinely different plants with different chemistry and different uses:

Artemisia annua (sweet wormwood, qinghao) — the subject of this page, and the source of artemisinin. This is the malaria plant.
Artemisia absinthium (wormwood) — a different, bitter perennial, historically used for digestion and as the flavoring in absinthe. It contains thujone, not artemisinin. See our separate Wormwood page.
Artemisia vulgaris (mugwort) — another relative, used in traditional European and East Asian practice (including moxibustion). See our Mugwort page.

When you read about the "wormwood that cures malaria," the plant meant is almost always Artemisia annua. The others do not contain artemisinin and were never the source of the antimalarial drugs.

The Artemisinin Story: A Genuine Triumph

This is one of the great stories in modern medicine, and it is worth telling accurately. During the 1960s and 1970s, malaria was killing enormous numbers of people, and the parasite was becoming resistant to the standard drugs of the day, chloroquine and quinine. In China, a secret government research effort known as Project 523 set out to find new antimalarials, in part by systematically screening traditional herbal remedies.

A chemist named Tu Youyou led part of that search. Her team combed through classical Chinese medical texts and repeatedly encountered qinghao — Artemisia annua — for fevers. Early extracts were disappointing, until Tu noticed a crucial detail in a fourth-century handbook by the physician Ge Hong, which described soaking the herb in cold water and wringing out the juice, rather than boiling it. That hint suggested the active ingredient was being destroyed by heat. Switching to a low-temperature extraction, her team isolated a pure compound in 1972 that reliably killed malaria parasites. It was named artemisinin (qinghaosu).

Artemisinin and its chemical derivatives (such as artesunate, artemether, and dihydroartemisinin) turned out to be faster and more powerful than any antimalarial then available, and they worked against parasites that had grown resistant to older drugs. They became the most important antimalarial medicines in the world. In 2015, Tu Youyou was awarded the Nobel Prize in Physiology or Medicine — the first Chinese woman to win a science Nobel — for this discovery. It is a rare and genuine example of an ancient herbal tradition pointing modern science toward a specific molecule that has since saved millions of lives.

The Drug Versus the Herb: The Distinction That Matters Most

Here is the single most important thing on this page. The triumph above is a triumph of the purified, precisely dosed drug — not of drinking the plant. Modern malaria treatment uses artemisinin-based combination therapy (ACT): a controlled dose of an artemisinin derivative paired with a second, longer-acting antimalarial. ACT is the frontline, life-saving standard of care recommended worldwide.

The raw herb, an "Artemisia annua tea," or homemade capsules and tablets are a different thing entirely, and they are not an adequate or safe way to treat malaria. The World Health Organization explicitly discourages using Artemisia annua plant material — in any form, including tea and tablets — to treat or to prevent malaria. The reasons are concrete and well understood:

The dose is uncontrolled and usually too low. The amount of artemisinin in a plant varies enormously with the variety, growing conditions, harvest time, and how the tea or tablet is prepared. A cup of tea delivers a small, unpredictable fraction of a therapeutic dose.
Sub-therapeutic dosing lets malaria come back. An under-dosed treatment can knock the parasite down enough for a person to feel briefly better, only to relapse — sometimes into severe, life-threatening malaria — when the surviving parasites rebound.
It actively drives drug resistance. Exposing malaria parasites to low, wavering levels of artemisinin from the plant is exactly the condition that selects for resistant parasites. That threatens not just the person drinking the tea but the effectiveness of the real drug for everyone. This is why the herb is treated as a public-health hazard, not a folk shortcut.

To be blunt: if you or someone you know may have malaria, the answer is prompt diagnosis and a proper course of ACT from a clinic — never a herbal tea. This is one of the few places on this whole site where the science is genuinely unambiguous.

How Artemisinin Works

Artemisinin's power comes from an unusual piece of chemistry: a peroxide bridge (an endoperoxide), which is a fragile "-O-O-" link built into the molecule. Most drugs do not carry a structure like this, and it is the key to how artemisinin acts.

Inside a red blood cell, the malaria parasite feeds on hemoglobin and releases large amounts of iron and heme. That iron reacts with artemisinin's peroxide bridge and rips it open, generating a burst of highly reactive free radicals. Those radicals then attack many different proteins and membranes inside the parasite more or less indiscriminately — damaging so many targets at once that the parasite cannot easily survive or adapt. In effect, the parasite's own iron-rich diet is what activates the drug that kills it, and it does so selectively where the parasite is most active. Researchers still debate some of the finer points of the mechanism, but the endoperoxide-plus-iron activation is the accepted core of how it works.

Why Resistance Is the Central Concern

Because artemisinins are so valuable, protecting them is a global priority. History gives the reason: malaria has defeated one wonder drug after another (quinine, then chloroquine, then others) whenever those drugs were used carelessly as single agents. Partial resistance to artemisinin has already emerged and spread — first documented in the Greater Mekong region of Southeast Asia, where treatments began clearing parasites more slowly than they should, and later linked to outright treatment failures when the partner drug was also weakened.

This is exactly why malaria is treated with a combination (ACT) rather than artemisinin alone: pairing it with a second drug makes it far harder for the parasite to survive and become resistant. And it is exactly why using the plant as a home remedy is so dangerous. An "Artemisia tea" is uncontrolled monotherapy at a low, fluctuating dose — the textbook recipe for breeding resistance. Undermining artemisinin would be a catastrophe, because there is no equally good replacement waiting in line.

Other Research on the Herb and Artemisinin

Beyond malaria, artemisinin and its derivatives have attracted scientific curiosity for a range of other conditions — and here we have to be careful and honest, because interest is not the same as proof.

Cancer. The same iron-activated, radical-generating chemistry that harms malaria parasites also damages some cancer cells in the laboratory, and cancer cells are often iron-hungry. This has driven a large body of preclinical (cell and animal) research and some early human studies. It is a legitimate area of investigation, but it remains experimental; artemisinin is not an established cancer treatment, and no one should substitute the herb for cancer care.
Other parasites and infections. Artemisinin derivatives have real, approved uses against certain parasites (for example, artemisinins are used in schistosomiasis control in some settings) and are being studied against others. These are uses of the drug under medical supervision, not endorsements of the tea.
Inflammation and immune conditions. Some derivatives show anti-inflammatory or immune-modulating effects in laboratory models, and a few are in early clinical study. This work is preliminary.

The honest summary: for the purified compounds, there is genuine, ongoing science beyond malaria, some of it promising. For the whole herb or tea, evidence in these other areas is largely preliminary and does not support self-treatment. Please do not use Artemisia annua to try to treat cancer, a serious infection, or any grave illness. Doing so can waste the narrow window in which effective medical treatment would help.

Traditional, Culinary, and Antioxidant Aspects

In traditional Chinese medicine, qinghao was classified as a cooling herb and used chiefly for "heat" patterns and intermittent fevers — a tradition that, remarkably, pointed straight at its antimalarial value. The plant is not a culinary herb in the way basil or thyme are, but its sweet, camphor-like aroma has long made it popular in dried arrangements, wreaths, and sachets; "sweet Annie" is a familiar craft plant for exactly this reason.

Like many green aromatic plants, Artemisia annua also contains flavonoids and other antioxidant compounds, and laboratory assays of its extracts show antioxidant activity. This is unremarkable — it is true of a great many leafy plants — and it should not be confused with the plant's medicinal reputation, which rests entirely on artemisinin. Antioxidant activity in a test tube is not evidence that drinking the tea treats disease.

Forms, Use, and the Standardization Problem

You will see Artemisia annua sold as dried loose herb, tea bags, capsules and tablets of powdered leaf, tinctures, and standardized extracts. The pharmaceutical drugs (artesunate, artemether, dihydroartemisinin) are entirely separate, prescription products — they are not what is in a supplement bottle.

The central practical problem with the plant itself is standardization and bioavailability:

Wildly variable content. Artemisinin makes up only a small percentage of the dried leaf, and that percentage swings dramatically between cultivars, climates, soils, and harvest timing. Two identical-looking jars can differ many-fold in strength.
Poor solubility and absorption. Artemisinin is not very water-soluble, so a hot-water tea extracts only part of what is present, and the body absorbs it inconsistently. This is precisely the unreliability that pharmaceutical chemists engineered around when they created the water- and fat-soluble derivatives used in real medicines.
No dependable dose. Put together, these facts mean the plant cannot deliver a predictable, therapeutic dose. That is a fatal flaw for treating a disease like malaria, where the dose has to be right.

If a person chooses to use the herb for mild traditional purposes (as an aromatic bitter, say), the standardization problem matters less. For anything that actually needs a reliable dose, the plant simply cannot provide one — which is the whole reason the isolated drug exists.

Safety and Cautions

In modest amounts, Artemisia annua herb or a light tea is generally tolerated by most healthy adults. But "generally tolerated" is not the same as "safe for treating disease," and there are real cautions:

Never use it to self-treat malaria or any serious infection. This is the most important safety point on the page, and it bears repeating: uncontrolled dosing risks relapse, severe disease, and the breeding of drug resistance.
Digestive and rare liver effects. Nausea, stomach upset, and diarrhea can occur. Artemisinin compounds have occasionally been associated with liver enzyme changes and, rarely, liver injury; anyone with liver disease should be especially cautious.
Drug interactions. Artemisinin compounds can affect the liver's drug-metabolizing enzymes (the cytochrome P450 system), which means they can raise or lower blood levels of other medicines. If you take prescription drugs — especially ones with a narrow safety margin — talk to a pharmacist or doctor first.
Avoid in pregnancy. There are two independent reasons to steer clear during pregnancy. First, Artemisia species have a long traditional reputation as emmenagogues (agents thought to stimulate the uterus). Second, and more concretely, artemisinin compounds have shown embryotoxicity in early-pregnancy animal studies, and health authorities advise against artemisinin use in the first trimester unless there is no safe alternative. The prudent course is to avoid the herb entirely while pregnant or trying to conceive.
Allergy. As a member of the daisy/ragweed family (Asteraceae), it can trigger reactions in people sensitive to that family.

The Honest Bottom Line

Artemisia annua is a plant of enormous medical importance — but that importance flows almost entirely through the purified drug artemisinin, not through the leaf in a cup. The discovery of artemisinin is a real scientific triumph worth celebrating, and artemisinin-based combination therapy is a frontline treatment that saves lives every day. At the same time, the evidence is unambiguous that the raw herb, tea, or homemade tablets should not be relied upon to treat malaria or any serious disease. Doing so risks treatment failure, dangerous relapse, and the spread of resistance that could blunt one of medicine's best tools. Respect the plant for what it gave the world; get the actual medicine, and proper diagnosis, from a clinician when it matters.

Research Papers

Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nature Medicine. 2011;17(10):1217–1220. doi:10.1038/nm.2471 — Tu Youyou's own account of how Artemisia annua and an ancient text led to artemisinin.
Tu Y. Artemisinin—a gift from traditional Chinese medicine to the world (Nobel Lecture). Angewandte Chemie International Edition. 2016;55(35):10210–10226. doi:10.1002/anie.201601967 — the Nobel lecture describing the discovery and its impact.
Meshnick SR. Artemisinin: mechanisms of action, resistance and toxicity. International Journal for Parasitology. 2002;32(13):1655–1660. doi:10.1016/S0020-7519(02)00194-7 — explains the endoperoxide/iron mechanism and early resistance concerns.
Wang J, Zhang C, Chia WN, et al. Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum. Nature Communications. 2015;6:10111. doi:10.1038/ncomms10111 — shows heme activates artemisinin to damage hundreds of parasite proteins.
Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. American Journal of Tropical Medicine and Hygiene. 2007;77(6 Suppl):181–192. doi:10.4269/ajtmh.2007.77.181 — the rationale for pairing artemisinin with a partner drug (ACT).
White NJ. Qinghaosu (artemisinin): the price of success. Science. 2008;320(5874):330–334. doi:10.1126/science.1155165 — warns how monotherapy and poor-quality products threaten artemisinin's future.
Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine. 2009;361(5):455–467. doi:10.1056/NEJMoa0808859 — the first clear documentation of artemisinin resistance, in the Mekong region.
Ashley EA, Dhorda M, Fairhurst RM, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine. 2014;371(5):411–423. doi:10.1056/NEJMoa1314981 — maps the geographic spread of slower parasite clearance across Asia.
van der Pluijm RW, Imwong M, Chau NH, et al. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam. The Lancet Infectious Diseases. 2019;19(9):952–961. doi:10.1016/S1473-3099(19)30391-3 — shows how resistance can translate into real treatment failures.
de Ridder S, van der Kooy F, Verpoorte R. Artemisia annua as a self-reliant treatment for malaria in developing countries. Journal of Ethnopharmacology. 2008;120(3):302–314. doi:10.1016/j.jep.2008.09.017 — a balanced review of the "herbal tea" idea and its dosing and resistance pitfalls.
Efferth T. From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. Seminars in Cancer Biology. 2017;46:65–83. doi:10.1016/j.semcancer.2017.02.009 — reviews the preclinical, still-experimental cancer research on artemisinin.
Clark RL. Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester. Reproductive Toxicology. 2009;28(3):285–296. doi:10.1016/j.reprotox.2009.05.002 — the basis for caution about artemisinins in early pregnancy.

Back to Table of Contents

Connections